Prenatal Exposure to DES Linked to Breast Cancer

Pharmaceutical Lawsuit and Recall Information

After the drug diethylstilbestrol (DES) was taken off the market, several studies revealed that the medication could potentially cause reproductive tract defects and cancers in girls born to mothers who took the drug during pregnancy. Recently, a group of breast cancer patients have filed suit in a Boston court, claiming their cancers were caused by [...]